Welcome to LookChem.com Sign In|Join Free
  • or
P7C3 is an orally bioavailable and brain penetrant aminopropyl carbazole that exhibits proneurogenic and neuroprotective activity by preventing apoptosis of newly postmitotic neurons in the subgranular zone of the hippocampal dentate gyrus.
Used in Pharmaceutical Industry:
P7C3 is used as a potential drug for the treatment of neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and traumatic brain injury due to its proneurogenic and neuroprotective properties.
Used in Research and Development:
P7C3 and its analogs are used in neurodegenerative disease research to study the process of neurogenesis in brain regions such as the subgranular zone of the hippocampal dentate gyrus.
Used in Drug Development:
P7C3 and its analogs may be used to study its pharmacokinetics, metabolism, safety, efficacy, and methods of delivery as potential drugs for the treatment of neurodegenerative conditions.

301353-96-8

Post Buying Request

301353-96-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

301353-96-8 Usage

Biochem/physiol Actions

P7C3 is neurogenic and protects new neurons against apoptosis. These activities may be related to its capacity to protect mitochondrial integrity.Degeneration of the hippocampus is an early manifestation of Alzheimer′s disease. P7C3 promotes neurogenesis in the subgranular zone of the hippocampal dentate gyrus, the site of normal neurogenesis in adult mammals, making it an important lead compound in development of new Alzheimer′s treatments.

References

1) Pieper et al. (2010), Discovery of a proneurogenic, neuroprotective chemical; Cell, 142 39 2) Tesla et al. (2012), Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis; Proc. Natl. Acad. Sci. USA, 109 17016 3) De Jesus-Cortes et al. (2012), Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease; Proc. Natl. Acad. Sci. USA, 109 17010 4) Latchney et al. (2015), Chronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of Down Syndrome; Neurosci. Lett. 591 86 5) Wang et al. (2014), P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage; Cell, 158 1324

Check Digit Verification of cas no

The CAS Registry Mumber 301353-96-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,3,5 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 301353-96:
(8*3)+(7*0)+(6*1)+(5*3)+(4*5)+(3*3)+(2*9)+(1*6)=98
98 % 10 = 8
So 301353-96-8 is a valid CAS Registry Number.

301353-96-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (D8446)  P7C3  ≥98% (HPLC)

  • 301353-96-8

  • D8446-5MG

  • 1,187.55CNY

  • Detail
  • Sigma

  • (D8446)  P7C3  ≥98% (HPLC)

  • 301353-96-8

  • D8446-25MG

  • 4,819.23CNY

  • Detail

301353-96-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-anilino-3-(3,6-dibromocarbazol-9-yl)propan-2-ol

1.2 Other means of identification

Product number -
Other names 1-(3,6-dibromo-9H-carbazol-9-yl)-3-(phenylamino)propan-2-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:301353-96-8 SDS

301353-96-8Downstream Products

301353-96-8Relevant academic research and scientific papers

Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays

Connelly, Colleen M.,Boer, Robert E.,Moon, Michelle H.,Gareiss, Peter,Schneekloth, John S.

, p. 435 - 443 (2017/02/26)

The identification of small molecules that bind to and perturb the function of microRNAs is an attractive approach for the treatment for microRNA-associated pathologies. However, there are only a few small molecules known to interact directly with microRN

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 301353-96-8